Literature DB >> 20147986

Chronic DLL4 blockade induces vascular neoplasms.

Minhong Yan1, Christopher A Callahan, Joseph C Beyer, Krishna P Allamneni, Gu Zhang, John Brady Ridgway, Kyle Niessen, Greg D Plowman.   

Abstract

Delta-like 4 (DLL4)-mediated Notch signalling has emerged as an attractive target for cancer therapy. However, the potential side effects of blocking this pathway remain uncertain. Here we show that chronic DLL4 blockade causes pathological activation of endothelial cells, disrupts normal organ homeostasis and induces vascular tumours, raising important safety concerns.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20147986     DOI: 10.1038/nature08751

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  7 in total

1.  Promoting angiogenesis to a fault.

Authors:  Daniel J Hicklin
Journal:  Nat Biotechnol       Date:  2007-03       Impact factor: 54.908

2.  Tumour suppressors: Different roads to inactivation.

Authors:  Sarah Seton-Rogers
Journal:  Nat Rev Cancer       Date:  2009-09       Impact factor: 60.716

3.  Blockade of Dll4 inhibits tumour growth by promoting non-productive angiogenesis.

Authors:  Irene Noguera-Troise; Christopher Daly; Nicholas J Papadopoulos; Sandra Coetzee; Pat Boland; Nicholas W Gale; Hsin Chieh Lin; George D Yancopoulos; Gavin Thurston
Journal:  Nature       Date:  2006-12-21       Impact factor: 49.962

4.  Inhibition of Dll4 signalling inhibits tumour growth by deregulating angiogenesis.

Authors:  John Ridgway; Gu Zhang; Yan Wu; Scott Stawicki; Wei-Ching Liang; Yvan Chanthery; Joe Kowalski; Ryan J Watts; Christopher Callahan; Ian Kasman; Mallika Singh; May Chien; Christine Tan; Jo-Anne S Hongo; Fred de Sauvage; Greg Plowman; Minhong Yan
Journal:  Nature       Date:  2006-12-21       Impact factor: 49.962

5.  Galectin-1, a novel ligand of neuropilin-1, activates VEGFR-2 signaling and modulates the migration of vascular endothelial cells.

Authors:  S H Hsieh; N W Ying; M H Wu; W F Chiang; C L Hsu; T Y Wong; Y T Jin; T M Hong; Y L Chen
Journal:  Oncogene       Date:  2008-01-28       Impact factor: 9.867

6.  EGFL7 regulates the collective migration of endothelial cells by restricting their spatial distribution.

Authors:  Maike Schmidt; Kim Paes; Ann De Mazière; Tanya Smyczek; Stacey Yang; Alane Gray; Dorothy French; Ian Kasman; Judith Klumperman; Dennis S Rice; Weilan Ye
Journal:  Development       Date:  2007-07-11       Impact factor: 6.868

Review 7.  Crosstalk of VEGF and Notch pathways in tumour angiogenesis: therapeutic implications.

Authors:  Ji-Liang Li; Adrian L Harris
Journal:  Front Biosci (Landmark Ed)       Date:  2009-01-01
  7 in total
  133 in total

Review 1.  Potential therapeutic implications of cancer stem cells in glioblastoma.

Authors:  Lin Cheng; Shideng Bao; Jeremy N Rich
Journal:  Biochem Pharmacol       Date:  2010-05-10       Impact factor: 5.858

Review 2.  EGFL7: a unique angiogenic signaling factor in vascular development and disease.

Authors:  Donna Nichol; Heidi Stuhlmann
Journal:  Blood       Date:  2011-12-07       Impact factor: 22.113

Review 3.  Tips, stalks, tubes: notch-mediated cell fate determination and mechanisms of tubulogenesis during angiogenesis.

Authors:  Jennifer J Tung; Ian W Tattersall; Jan Kitajewski
Journal:  Cold Spring Harb Perspect Med       Date:  2012-02       Impact factor: 6.915

Review 4.  Notch signaling in ocular vasculature development and diseases.

Authors:  Guo-Rui Dou; Lin Wang; Yu-Sheng Wang; Hua Han
Journal:  Mol Med       Date:  2012-02-10       Impact factor: 6.354

Review 5.  Targeting Notch to target cancer stem cells.

Authors:  Antonio Pannuti; Kimberly Foreman; Paola Rizzo; Clodia Osipo; Todd Golde; Barbara Osborne; Lucio Miele
Journal:  Clin Cancer Res       Date:  2010-06-08       Impact factor: 12.531

Review 6.  Formation of cardiovascular tubes in invertebrates and vertebrates.

Authors:  Boris Strilić; Tomás Kucera; Eckhard Lammert
Journal:  Cell Mol Life Sci       Date:  2010-05-20       Impact factor: 9.261

7.  Spatially addressed combinatorial protein libraries for recombinant antibody discovery and optimization.

Authors:  Hongyuan Mao; James J Graziano; Tyson M A Chase; Cornelia A Bentley; Omar A Bazirgan; Neil P Reddy; Byeong Doo Song; Vaughn V Smider
Journal:  Nat Biotechnol       Date:  2010-10-24       Impact factor: 54.908

Review 8.  The double-edged sword of Notch signaling in cancer.

Authors:  Andrew P South; Raymond J Cho; Jon C Aster
Journal:  Semin Cell Dev Biol       Date:  2012-01-30       Impact factor: 7.727

9.  Molecular pathways: context-dependent approaches to Notch targeting as cancer therapy.

Authors:  Ann Marie Egloff; Jennifer R Grandis
Journal:  Clin Cancer Res       Date:  2012-07-06       Impact factor: 12.531

10.  DLL4/Notch1 and BMP9 Interdependent Signaling Induces Human Endothelial Cell Quiescence via P27KIP1 and Thrombospondin-1.

Authors:  Bahman Rostama; Jacqueline E Turner; Guy T Seavey; Christine R Norton; Thomas Gridley; Calvin P H Vary; Lucy Liaw
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-10-15       Impact factor: 8.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.